|
2025
|
G/S
|
Antibodies for medical purposes; Diagnostic biomarker reagents for medical purposes; Protein arra... |
|
|
Invention
|
Anti-ly6h antibodies and antibody drug conjugates.
Disclosed herein are anti-lymphocyte antigen ... |
|
2024
|
Invention
|
Anti-ilt3 antibodies and antibody drug conjugates.
Disclosed herein are anti-immunoglobulin-like... |
|
|
Invention
|
Anti-tmeff1 antibodies and antibody drug conjugates.
Disclosed herein are transmembrane protein ... |
|
|
Invention
|
Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of... |
|
|
Invention
|
Anti-vtcn1 antibodies and antibody drug conjugates. Disclosed herein are anti-V-set domain contai... |
|
2023
|
Invention
|
Methods of treating disease using anti-il1rap antibodies and antibody drug conjugates. Disclosed ... |
|
|
Invention
|
Anti-sez6l2 antibodies and antibody drug conjugates.
Disclosed herein are anti-Seizure Related 6... |
|
2022
|
Invention
|
Anti-ly6h antibodies and antibody drug conjugates. Disclosed herein are anti-lymphocyte antigen 6... |
|
|
Invention
|
Anti-tmeff1 antibodies and antibody drug conjugates. Disclosed herein are transmembrane protein w... |
|
|
Invention
|
Anti-ilt3 antibodies and antibody drug conjugates. Disclosed herein are anti-immunoglobulin-like ... |
|
2021
|
Invention
|
Nucleic acids encoding anti-il1rap antibodies and their uses. Disclosed herein are Interleukin 1 ... |
|
2018
|
Invention
|
Anti-il1rap antibodies and antibody drug conjugates. Disclosed herein are Interleukin 1 Receptor ... |
|
2017
|
Invention
|
Anti-sez6l2 antibodies and antibody drug conjugates. Disclosed herein are anti-Seizure Related 6 ... |
|
2014
|
Invention
|
Anti-mucin 1 binding agents and uses thereof. This disclosure provides anti-MUC1 binding agents (... |
